Sonoma Pharmaceuticals SG&A Expense (Quarterly) Insights

Sonoma Pharmaceuticals Inc (SNOA)

0.159 0.00 (0.00%) USD | NASDAQ | Apr 26, 16:00

0.1602 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2006. Upgrade now.

Date	Value
December 31, 2023	1.703M
September 30, 2023	1.662M
June 30, 2023	2.119M
March 31, 2023	1.81M
December 31, 2022	2.665M
September 30, 2022	2.067M
June 30, 2022	2.295M
March 31, 2022	3.152M
December 31, 2021	2.135M
September 30, 2021	2.195M
June 30, 2021	2.273M
March 31, 2021	2.49M
December 31, 2020	2.10M
September 30, 2020	2.418M
June 30, 2020	2.444M
March 31, 2020	4.394M
December 31, 2019	2.861M
September 30, 2019	3.192M
June 30, 2019	3.726M
March 31, 2019	4.252M
December 31, 2018	4.746M
September 30, 2018	4.689M
June 30, 2018	4.933M
March 31, 2018	5.605M
December 31, 2017	5.219M

Date	Value
September 30, 2017	4.337M
June 30, 2017	4.763M
March 31, 2017	4.509M
December 31, 2016	4.784M
September 30, 2016	3.643M
June 30, 2016	4.13M
March 31, 2016	4.145M
December 31, 2015	4.158M
September 30, 2015	3.536M
June 30, 2015	3.717M
March 31, 2015	3.272M
December 31, 2014	3.238M
September 30, 2014	2.923M
June 30, 2014	2.981M
March 31, 2014	2.769M
December 31, 2013	2.88M
September 30, 2013	3.093M
June 30, 2013	2.819M
March 31, 2013	2.901M
December 31, 2012	2.642M
September 30, 2012	3.504M
June 30, 2012	2.847M
March 31, 2012	3.124M
December 31, 2011	3.697M
September 30, 2011	2.848M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.662M

Minimum

Sep 2023

4.394M

Maximum

Mar 2020

2.511M

Average

2.295M

Median

Jun 2022

SG&A Expense (Quarterly) Benchmarks